BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 28992308)

  • 1. Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
    Wirth F; de Azevedo MI; Pilla C; Aquino VR; Neto GW; Goldani LZ
    Med Mycol; 2018 Apr; 56(3):257-262. PubMed ID: 28992308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
    Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
    Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing.
    Soares BM; Santos DA; Kohler LM; da Costa César G; de Carvalho IR; dos Anjos Martins M; Cisalpino PS
    Rev Iberoam Micol; 2008 Dec; 25(4):242-5. PubMed ID: 19071894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.
    Larsen RA; Bauer M; Thomas AM; Graybill JR
    Antimicrob Agents Chemother; 2004 Mar; 48(3):985-91. PubMed ID: 14982793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
    Shoji H; Takuma T; Ohbayashi H; Yoshida K; Yamamoto T; Niki Y
    J Infect Chemother; 2012 Oct; 18(5):775-9. PubMed ID: 22318291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the relationship between drug susceptibility of Cryptococcus neoformans isolates and mortality in HIV-negative cryptococcal meningitis.
    Su Z; Wei H; Liu J; Li C; Xu Z; Yuan D; Dai K; Peng F; Jiang Y
    J Glob Antimicrob Resist; 2024 Mar; 36():167-174. PubMed ID: 38141953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical study of 26 cases of cryptococcal meningitis].
    Liu Z; Wang A; Li T; Qin S; Sheng R
    Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):541-3. PubMed ID: 12421503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole: a novel treatment option for cryptococcal meningitis.
    Yao Y; Zhang JT; Yan B; Gao T; Xing XW; Tian CL; Huang XS; Yu SY
    Infect Dis (Lond); 2015; 47(10):694-700. PubMed ID: 26100526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania.
    Katende A; Mbwanji G; Faini D; Nyuri A; Kalinjuma AV; Mnzava D; Hullsiek KH; Rhein J; Weisser M; Meya DB; Boulware DR; Letang E;
    Mycoses; 2019 Dec; 62(12):1127-1132. PubMed ID: 31461550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
    AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
    [No Abstract]   [Full Text] [Related]  

  • 15. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
    Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
    Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
    Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
    Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y
    Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cryptococcal meningitis in Peruvian AIDS patients using amphotericin B and fluconazole.
    Dammert P; Bustamante B; Ticona E; Llanos-Cuentas A; Huaroto L; Chávez VM; Campos PE
    J Infect; 2008 Sep; 57(3):260-5. PubMed ID: 18707764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
    Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
    BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002.
    Sar B; Monchy D; Vann M; Keo C; Sarthou JL; Buisson Y
    J Antimicrob Chemother; 2004 Aug; 54(2):563-5. PubMed ID: 15254027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.